Florida Financial Advisors LLC lifted its holdings in Oracle Corporation (NYSE:ORCL – Free Report) by 225.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,257 shares of the enterprise software provider’s stock after purchasing an additional 9,183 shares during the quarter. Oracle accounts for approximately 1.2% of Florida Financial Advisors LLC’s investment portfolio, making the stock its 17th biggest holding. Florida Financial Advisors LLC’s holdings in Oracle were worth $3,729,000 at the end of the most recent quarter.
Several other large investors have also added to or reduced their stakes in the business. Darwin Wealth Management LLC lifted its position in Oracle by 130.0% during the 3rd quarter. Darwin Wealth Management LLC now owns 115 shares of the enterprise software provider’s stock worth $32,000 after buying an additional 65 shares in the last quarter. Winnow Wealth LLC acquired a new stake in shares of Oracle in the second quarter valued at about $28,000. Financial Consulate Inc. bought a new stake in Oracle during the third quarter worth about $37,000. Corundum Trust Company INC bought a new stake in Oracle during the third quarter worth about $39,000. Finally, Collier Financial acquired a new position in Oracle during the third quarter valued at approximately $38,000. Institutional investors and hedge funds own 42.44% of the company’s stock.
Oracle Stock Performance
Shares of ORCL stock opened at $160.19 on Friday. Oracle Corporation has a 52 week low of $118.86 and a 52 week high of $345.72. The company has a market capitalization of $460.24 billion, a price-to-earnings ratio of 30.11, a PEG ratio of 1.37 and a beta of 1.64. The company has a 50-day simple moving average of $183.73 and a 200 day simple moving average of $231.18. The company has a debt-to-equity ratio of 3.28, a quick ratio of 0.91 and a current ratio of 0.91.
Oracle Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, January 23rd. Shareholders of record on Friday, January 9th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date of this dividend was Friday, January 9th. Oracle’s dividend payout ratio is currently 37.59%.
Insider Transactions at Oracle
In other news, insider Mark Hura sold 15,000 shares of Oracle stock in a transaction on Wednesday, December 24th. The stock was sold at an average price of $196.89, for a total transaction of $2,953,350.00. Following the completion of the sale, the insider owned 234,077 shares of the company’s stock, valued at approximately $46,087,420.53. This trade represents a 6.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Clayton M. Magouyrk sold 10,000 shares of the business’s stock in a transaction dated Monday, February 9th. The shares were sold at an average price of $155.23, for a total transaction of $1,552,300.00. Following the completion of the sale, the chief executive officer directly owned 134,030 shares of the company’s stock, valued at approximately $20,805,476.90. The trade was a 6.94% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 72,223 shares of company stock worth $13,689,064 over the last quarter. 40.90% of the stock is currently owned by corporate insiders.
Key Stories Impacting Oracle
Here are the key news stories impacting Oracle this week:
- Positive Sentiment: Oracle won an $88 million U.S. Air Force task order for Oracle Cloud Infrastructure to support the Air Force Cloud One program through 2028 — a material, mission‑critical cloud contract that supports ORCL’s OCI revenue trajectory. U.S. Department of the Air Force Accelerates Cloud Modernization with Oracle
- Positive Sentiment: Oracle added several customer wins and product rollouts (City of Atlanta selects Oracle Permitting & Licensing; ReGrow Israel picks Oracle Agriculture Data Intelligence; Oracle Health Clinical AI Agent expands to the UK) — these wins reinforce recurring SaaS/OCI demand and demonstrate traction for Oracle’s AI‑enabled offerings. The City of Atlanta Modernizes Constituent Services and Unlocks AI-Driven Innovation with Oracle
- Positive Sentiment: Market interest is also being propped up by product momentum around AI agents for Fusion Apps and positive analyst notes/upgrades that have previously sparked rallies. Oracle Unveils AI Agents for Fusion Apps
- Neutral Sentiment: Scotiabank trimmed FY2026/FY2027 EPS forecasts slightly — small estimate moves that leave the firm constructive (Sector Outperform) but signal analysts are recalibrating near‑term expectations. Scotiabank Lowers FY2026/FY2027 EPS Estimates for Oracle
- Negative Sentiment: Legal overhang: multiple law firms have filed or are soliciting plaintiffs for securities‑class actions covering June–December 2025 — this increases litigation risk and could pressure the stock if suits progress. STOCK NEWS: Oracle Corporation Sued for Securities Fraud after 11% Stock Drop
- Negative Sentiment: Insider selling & sentiment risk: CEO Clayton Magouyrk disclosed a ~10,000‑share sale this week; while often personal, it can be read negatively alongside analyst caution and rising short interest. SEC Form 4 — Clayton M. Magouyrk sale
Analyst Ratings Changes
A number of brokerages have recently issued reports on ORCL. Bank of America dropped their price objective on Oracle from $368.00 to $300.00 and set a “buy” rating on the stock in a research note on Thursday, December 11th. TD Cowen dropped their price target on shares of Oracle from $400.00 to $350.00 and set a “buy” rating on the stock in a research report on Thursday, December 11th. Melius Research set a $160.00 price target on shares of Oracle in a research note on Monday. Jefferies Financial Group restated a “buy” rating and set a $400.00 price objective on shares of Oracle in a research note on Monday, January 5th. Finally, UBS Group reiterated a “buy” rating on shares of Oracle in a research note on Monday, February 2nd. Three research analysts have rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $292.43.
Read Our Latest Research Report on ORCL
Oracle Company Profile
Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.
Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.
Further Reading
- Five stocks we like better than Oracle
- ALERT: Drop these 5 stocks before January 2026!
- Buy This Stock Now
- Trump Planning to Use Public Law 63-43: Prepare Now
- Trump & Musk’s Secret Bet on Silver — Exposed
- Trump’s AI Secret: 100X Faster Than Nvidia
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
